Coronary Artery Bypass Grafting Guidelines
Introduction to CABG
- The American College of Cardiology recommends grafting the left anterior descending (LAD) artery, the left circumflex (LCx) artery, and the right coronary artery (RCA) in coronary artery bypass grafting (CABG) 1, 2, 3
Vessel Grafting Considerations
- The American Heart Association suggests that the LAD artery is the most important target vessel in CABG, with the left internal mammary artery (LIMA) being the preferred conduit for this vessel 1, 2
- The LAD supplies the anterior wall and apex of the left ventricle, making it critical for cardiac function 3
- Proximal LAD stenosis is considered a high-risk lesion that significantly benefits from surgical revascularization 4, 5
- The left circumflex artery is typically the second most important vessel targeted in CABG, supplying the lateral wall of the left ventricle and sometimes part of the posterior wall 6, 7, 3
- The RCA is the third major vessel commonly targeted in CABG, supplying the right ventricle and, in most cases, the inferior wall of the left ventricle 1, 2, 3
Grafting Recommendations
- The American College of Cardiology recommends arterial grafting of the RCA only when a critical stenosis (>90%) is present 1, 2
- For RCA grafting, saphenous vein grafts are commonly used, though arterial grafts may be considered in specific situations 1
- LIMA to LAD bypass is considered a Class I recommendation (highest level of recommendation) in all major cardiac surgery guidelines 1
Graft Patency and Outcomes
- Graft patency rates vary significantly by vessel and conduit type, with LIMA to LAD having the highest long-term patency (>90% at 10 years) 1, 2
- Radial artery grafts show superior patency compared to saphenous vein grafts (89% vs 65-80% at 4-5 years) 6
- Saphenous vein grafts have declining patency over time (25-50% at 10-15 years) 6
Patient Selection and Disease Patterns
- The decision to graft these vessels depends on the degree of stenosis (typically >70% for LAD and LCx, >90% for RCA) 1, 2
- Viability of the myocardium supplied by the vessel is also a key consideration 5
- The patient's overall coronary anatomy and disease pattern should be taken into account when making grafting decisions 5
Clinical Significance and Outcomes
- Grafting these three main vessels is particularly important in patients with left main coronary artery disease 3, 8
- Complete revascularization (addressing all three territories when diseased) generally provides better long-term outcomes than incomplete revascularization 5
Coronary Artery Bypass Grafting Guidelines
Graft Selection and Outcomes
- Bilateral internal mammary arteries (BIMA) provide survival benefit in younger patients with multivessel disease, as recommended by the European Society of Cardiology 9, 10
- Saphenous vein grafts have declining patency over time (25-50% at 10-15 years), particularly when used for distal targets and severely diseased small vessels, according to the European Heart Journal 9
Surgical Approaches
- Traditional CABG is performed via median sternotomy, which provides access to all coronary territories, as described in the European Heart Journal 11
- Minimally invasive direct coronary artery bypass (MIDCAB) is primarily limited to the LAD and diagonal branches through a left minithoracotomy, as reported in the European Heart Journal 9
- Totally endoscopic coronary artery bypass (TECAB) can achieve complete revascularization in selected patients at specialized centers, according to the European Heart Journal 9, 10
Pitfalls and Caveats
- Endoscopic vein graft harvesting should be approached with caution as it has been associated with vein graft failure and adverse clinical outcomes, as warned by the European Heart Journal 11
- The rate of early vein graft failure is high (10-26% between 12-18 months) especially when used for distal targets and severely diseased small vessels, as noted in the European Heart Journal 9, 10
- While hybrid procedures combining MIDCAB with percutaneous intervention show promise, randomized trials are still lacking, as reported in the European Heart Journal 9, 10